Table 1 Patient demographics by diagnostic group
From: Evidence-based cardiovascular care in the community: A population-based cross-sectional study
Previous Diagnosis | Recommended Rx | No. of patients | Males No. (%) | Females No. (%) | Age ≤ 74 No. (%) | Age ≥ 75 No. (%) |
|---|---|---|---|---|---|---|
IHD | Antithrombotic (Grade A*, Class I**) | 6805 | 4217 (62.0) | 2588 (38.0) | 4281 (62.9) | 2524 (37.1) |
MI | Beta-blocker (Grade A, Class I) | 5526 | 3509 (63.5) | 2017 (36.5) | 3398 (61.5) | 2128 (38.5) |
IHD + hyperlipidemia | Lipid-lowering agent (Grade A, Class II***) | 3210 | 2071 (64.5) | 1139 (35.5) | 2573 (80.2) | 637 (19.8) |
IHD + hypertension | Antihypertensive agent (Grade A, Class I) | 3594 | 2046 (56.9) | 1548 (43.1) | 2205 (61.4) | 1389 (38.6) |
IHD + CHF | ACEI (Grade A, Class I) | 3490 | 1695 (48.6) | 1795 (51.4) | 1361 (39.0) | 2129 (61.0) |